1,633
Views
16
CrossRef citations to date
0
Altmetric
Review

The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies

, , , , , , , , & show all
Pages 889-898 | Received 18 Apr 2016, Accepted 03 Jul 2016, Published online: 11 Aug 2016

References

  • Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140:1785-94; PMID:21530745; http://dx.doi.org/10.1053/j.gastro.2011.01.055
  • Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504-17; PMID:15168363; http://dx.doi.org/10.1053/j.gastro.2004.01.063
  • Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 2014; 11:88-98; PMID:24345891; http://dx.doi.org/10.1038/nrgastro.2013.240
  • Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46-54; PMID:22001864; http://dx.doi.org/10.1053/j.gastro.2011.10.001
  • Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101:993-1002; PMID:16696783; http://dx.doi.org/10.1111/j.1572-0241.2006.00381.x
  • Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-24; PMID:23128233; http://dx.doi.org/10.1038/nature11582
  • Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474:307-17; PMID:21677747; http://dx.doi.org/10.1038/nature10209
  • Ananthakrishnan A. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015; 12:205-17; PMID:25732745; http://dx.doi.org/10.1038/nrgastro.2015.34
  • Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E, Toruner M, Marti-Gallostra M, Spinelli A, van der Meulen-de Jong AE, Yuksel ES, et al. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis 2014; 8:5-18; PMID:23664897; http://dx.doi.org/10.1016/j.crohns.2013.04.008
  • Dalerba P, Cho RW, Clarke MF. Cancer stem cells: Models and concepts. Annu Rev Med 2007; 58:267-284; PMID:17002552; http://dx.doi.org/10.1146/annurev.med.58.062105.204854
  • Todaro M, Francipane MG, Medema JP, Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010; 138:2151-62; PMID:20420952; http://dx.doi.org/10.1053/j.gastro.2009.12.063
  • Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 2008; 43:1-17; PMID:18297430; http://dx.doi.org/10.1007/s00535-007-2111-3
  • Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380:1590-605; PMID:22914295; http://dx.doi.org/10.1016/S0140-6736(12)60026-9
  • Freeman HJ. Natural history and long-term clinical course of Crohn's disease. World J Gastroenterol 2014; 20:31-36; PMID:24415855; http://dx.doi.org/10.3748/wjg.v20.i1.31
  • Moller FT, Andersen V, Wohlfahrt J, Jess T. Familial risk of inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2015; 110:564-71; PMID:25803400; http://dx.doi.org/10.1038/ajg.2015.50
  • Plevy S. The immunology of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31:77-92; PMID:12122745; http://dx.doi.org/10.1016/S0889-8553(01)00006-1
  • Sherbaniuk RW. Ulcerative colitis: disease patterns and medical management. CMAJ 1964; 91:30-6; PMID:14182561
  • Gerlach K, Hwang Y, Nikolaevetal A. H9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol 2014; 15:676-86; PMID:24908389; http://dx.doi.org/10.1038/ni.2920
  • Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2009; 15:5784-88; PMID:19998498; http://dx.doi.org/10.3748/wjg.15.5784
  • De Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM, Simioni PU. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments. Mediators Inflamm 2015; 2015:493012; PMID:26339135; http://dx.doi.org/10.1155/2015/493012
  • Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(Suppl A):5A-36A; PMID:16151544; http://dx.doi.org/10.1155/2005/269076
  • Bressenot A, Cahn V, Danese S, Peyrin-Biroulet L. Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol 2014; 20:3164-72; PMID:24696602; http://dx.doi.org/10.3748/wjg.v20.i12.3164
  • Shergill AK, Farraye FA. Toward a Consensus on Endoscopic Surveillance of Patients with Colonic Inflammatory Bowel Disease. Gastrointest Endoscopy Clin N Am 2014; 24:469-81; PMID:24975537; http://dx.doi.org/10.1016/j.giec.2014.03.006
  • Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138:746-74; PMID:20141809; http://dx.doi.org/10.1053/j.gastro.2009.12.035
  • Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:314-21, Leighton JA, Shen B, Baron TH, et al. ASGE guideline: endoscopy in the diag- nosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006; 63:558-65; PMID:16564852; http://dx.doi.org/10.1097/01.MIB.0000160811.76729.d5
  • Hughes KR, Gândara RM, Javkar T, Sablitzky F, Hock H, Potten CS, Mahida YR. Heterogeneity in histone 2B-green fluorescent protein-retaining putative small intestinal stem cells at cell position 4 and their absence in the colon. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1188-201; PMID:22997199; http://dx.doi.org/10.1152/ajpgi.00080.2012
  • Westphalen CB, Asfaha S, Hayakawa Y, Takemoto Y, Lukin DJ, Nuber AH, Brandtner A, Setlik W, Remotti H, Muley A, et al. Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J Clin Invest 2014 Mar;124(3):1283-95; PMID: 24487592; http://dx.doi.org/10.1172/JCI73434
  • Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. I. Evidence from Paneth cells in the adult mouse. Am J Anat 1981; 160:51-63; PMID:7211716; http://dx.doi.org/10.1002/aja.1001600105
  • Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. II. Evidence from Paneth cells in the newborn mouse. Am J Anat 1981; 160:65-75; PMID:7211717; http://dx.doi.org/10.1002/aja.1001600106
  • Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. III. Evidence from columnar, enteroendocrine, and mucous cells in the adult mouse. Am J Anat 1981; 160:77-91; PMID:7211718; http://dx.doi.org/10.1002/aja.1001600107
  • Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. IV. Effects of resectng 30% of the small intestine. Am J Anat 1981; 160:93-103; PMID:7211719; http://dx.doi.org/10.1002/aja.1001600108
  • Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. V. Evidence for controls over orientation of boundaries between the stem-cell zone, proliferative zone, and the maturation zone. Am J Anat 1981; 160:105-12; PMID:7211714; http://dx.doi.org/10.1002/aja.1001600109
  • Bjerknes M, Cheng H. Intestinal epithelial stem cells and progenitors. Methods Enzymol 2006; 419:337-83; PMID:17141062; http://dx.doi.org/10.1016/S0076-6879(06)19014-X
  • Potten CS, Chadwick C, Ijiri K, Tsubouchi S, Hanson WR. The recruitability and cell-cycle state of intestinal stem cells. Int J Cell Cloning 1984; 2:126-40; PMID:6707492; http://dx.doi.org/10.1002/stem.5530020206
  • Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110:1001-20; PMID:2100251
  • Potten CS, Booth C, Pritchard DM. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 1997; 78:219-43; PMID:9505935; http://dx.doi.org/10.1046/j.1365-2613.1997.280362.x
  • Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449:1003-7; PMID:17934449; http://dx.doi.org/10.1038/nature06196
  • Moossavi S, Zhang H, Sun J, Rezaei N. Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer. Expert Rev Clin Immunol 2013; 9:409-22; PMID:23634736; http://dx.doi.org/10.1586/eci.13.27
  • Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459:262-5; PMID:19329995; http://dx.doi.org/10.1038/nature07935
  • Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 2014; 15:19-33; PMID:24326621; http://dx.doi.org/10.1038/nrm3721
  • Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011; 474:318-326; PMID:21677748; http://dx.doi.org/10.1038/nature10212
  • Lanzoni G, Alviano F, Marchionni C, Bonsi L, Costa R, Foroni L, Roda G, Belluzzi A, Caponi A, Ricci F, et al. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. Cytotherapy 2009; 11:1020-31; PMID:19929466; http://dx.doi.org/10.3109/14653240903253840
  • Potten CS, Gandara R, Mahida YR, Loeffler M, Wright NA. The stem cells of small intestinal crypts: where are they? Cell Prolif 2009; 42:731-50; PMID:19788585; http://dx.doi.org/10.1111/j.1365-2184.2009.00642.x
  • Imai T, Tokunaga A, Yoshida T, Hashimoto M, Mikoshiba K, Weinmaster G, Nakafuku M, Okano H. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol 2001; 21:3888-900; PMID:11359897; http://dx.doi.org/10.1128/MCB.21.12.3888-3900.2001
  • Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, Ashton G, Clarke R, Sakakibara S, Okano H. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003; 71:28-41; PMID:12558601; http://dx.doi.org/10.1046/j.1432-0436.2003.700603.x
  • Breault DT, Min IM, Carlone DL, Farilla LG, Ambruzs DM, Henderson DE, Algra S, Montgomery RK, Wagers AJ, Hole N. Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc Natl Acad Sci U S A 2008; 105:10420-5; PMID:18650388; http://dx.doi.org/10.1073/pnas.0804800105
  • Levin TG, Powell AE, Davies PS, Silk AD, Dismuke AD, Anderson EC, Swain JR, Wong MH. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 2010; 139:2072-82; PMID:20826154; http://dx.doi.org/10.1053/j.gastro.2010.08.053
  • Wang F, Scoville D, He XC, Mahe MM, Box A, Perry JM, Smith NR, Lei NY, Davies PS, Fuller MK, et al. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology 2013; 145:383-95; PMID:23644405
  • Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R. Colon cancer stem cells. J Mol Med (Berl) 2009; 87:1097-104; PMID:19727638
  • Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, de Sauvage FJ. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011; 478:255-59; PMID:21927002
  • Gerbe F, Brulin B, Makrini L, Legraverend C, Jay P. DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium. Gastroenterology 2009; 137:2179-80; PMID:19879217
  • May R, Riehl TE, Hunt C, Sureban SM, Anant S, Houchen CW. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 2008; 26:630-637; PMID:18055444
  • Saqui-Salces M, Keeley TM, Grosse AS, Qiao XT, El-Zaatari M, Gumucio DL, Samuelson LC, Merchant JL. Gastric tuft cells express DCLK1 and are expanded in hyperplasia. Histochem Cell Biol 2011; 136:191-204; PMID:21688022
  • Cheng H, Bjerknes M, Amar J, Gardiner G. Crypt production in normal and diseased human colonic epithelium. Anat. Rec 1986; 216:44-48; PMID:3094402
  • Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science 2012; 338:108-113; PMID:22956684
  • Gersemann M, Stange EF, Wehkamp J. From intestinal stem cells to inflammatory bowel diseases. World J Gastroenterol 2011; 17:3198-203; PMID:21912468
  • Gersemann M, Becker S, Kübler I, Koslowski M, Wang G, Herrlinger KR, Griger J, Fritz P, Fellermann K, Schwab M. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 2009; 77:84-94; PMID:19281767
  • Wehkamp J, Wang G, Kübler I, Nuding S, Gregorieff A, Schnabel A, Kays RJ, Fellermann K, Burk O, Schwab M. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179:3109-18; PMID:17709525
  • Brittan M, Alison MR, Schier S, Wright NA. Bone marrow stem cell-mediated regeneration in IBD: where do we go from here? Gastroenterology 2007; 132:1171-73; PMID:17383436
  • Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53:V1-V16; PMID:15306569
  • D'Haens GR, Sartor RB, Silverberg MS, Petersson J, Rutgeerts P. Future directions in inflammatory bowel disease management. J Crohns Colitis 2014; 8:726-34; PMID:24742736; http://dx.doi.org/10.1016/j.crohns.2014.02.025
  • Reichel C, Streit J, Ott K, Wunsch S. Appropriateness of Crohn's disease therapy in gastroenterological rehabilitation. Digestion 2010; 82:239-45; PMID:20588039; http://dx.doi.org/10.1159/000291859
  • Sethu S, Govindappa K, Alhaidari M, Pirmohamed M, Park K, Sathish J. Immunogenicity to biologics: mechanisms, prediction and reduction. Arch Immunol Ther Exp 2012; 60:331-44; PMID:22930363; http://dx.doi.org/10.1007/s00005-012-0189-7
  • Pittenger MF. Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 2008; 449:27-44; PMID:18370081; http://dx.doi.org/10.1007/978-1-60327-169-1_2
  • De Francesco F, Ricci G, D'Andrea F, Nicoletti GF, Ferraro GA. Human Adipose Stem Cells: From Bench to Bedside. Tissue Eng Part B Rev 2015; 21:572-84; PMID:25953464; http://dx.doi.org/10.1089/ten.teb.2014.0608
  • Ledesma-Martinez E, Mendoza-Nunez VM, Santiago-Osorio E. Mesenchymal stem cells derived from dental pulp: A review. Stem Cells Int 2016; 2016:4709572; PMID:26779263; http://dx.doi.org/10.1155/2016/4709572
  • Vapniarsky N, Arzi B, Hu JC, Nolta JA, Athanasiou KA. Concise review: Human dermis as an autologous source of stem cells for tissue engineering and regenerative medicine. Stem Cells Transl Med 2015; 4:1187-98; PMID:26253713; http://dx.doi.org/10.5966/sctm.2015-0084
  • Kalaszczynska I, Ferdyn K. Wharton's jelly mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance. Biomed Res Int 2015; 2015:430847; PMID:25861624; http://dx.doi.org/10.1155/2015/430847
  • Tan DW, Barker N. Intestinal stem cells and their defining niche. Curr Top Dev Biol 2014; 107:77-107; PMID:24439803; http://dx.doi.org/10.1016/B978-0-12-416022-4.00003-2
  • Sousa BR, Parreira RC, Fonseca EA, Amaya MJ, Tonelli FM, Lacerda SM, Lalwani P, Santos AK, Gomes KN, Ulrich H, et al. Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry A 2014; 85:43-77; PMID:24700575; http://dx.doi.org/10.1002/cyto.a.22402
  • Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy 2016; 18:151-9; PMID:26724220; http://dx.doi.org/10.1016/j.jcyt.2015.11.008
  • Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F, Meng Y, Yuan Z. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue and Wharton's jelly as sources of cell immunomodulatory therapy. Hum Vaccin Immunother 2016; 12:85-96; PMID:26186552; http://dx.doi.org/10.1080/21645515.2015.1030549
  • Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 2014; 15:1009-16; PMID:25329189; http://dx.doi.org/10.1038/ni.3002
  • Molendijk L, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, van der Woude CJ, Duijvestein M, Veenendaal RA, Zwaginga JJ, et al. Allogenic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with crohn's disease. Gastroenterology 2015; 149:918-27; PMID:26116801; http://dx.doi.org/10.1053/j.gastro.2015.06.014
  • Dave M, Mehta K, Luther J, Baruah A, Dietz AB, Faubion WA Jr. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2015; 21:2696-707; PMID:26230863; http://dx.doi.org/10.1097/MIB.0000000000000543
  • Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP. A phase 2 study of allogenic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol 2014; 12:64-71; PMID:23872668; http://dx.doi.org/10.1016/j.cgh.2013.06.021
  • Duijvestein M, Wildenberg ME, Welling MM, Hennink S, Molendijk I, van Zuylen VL, Bosse T, Vos AC, de Jonge-Muller ES, Roelofs H, et al. Pretreatment with interferon-g enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 2011; 29:1549-58; PMID:21898680; http://dx.doi.org/10.1002/stem.698
  • Ando Y, Inaba M, Sakaguchi Y, Tsuda M, Quan GK, Omae M, Okazaki K, Ikehara S. Subcutaneous adipose tissue-derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)- induced colitis in rats. Inflamm Bowel Dis 2008; 14:826-38; PMID:18253953; http://dx.doi.org/10.1002/ibd.20382
  • Gonzalez-Rey E, Anderson P, Gonzalez MA, Rico L, Buscher D, Delfado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009; 58:929-39; PMID:19136511; http://dx.doi.org/10.1136/gut.2008.168534
  • Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009; 136:978-89; PMID:19135996; http://dx.doi.org/10.1053/j.gastro.2008.11.041
  • Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48:1416-23; PMID:15933795; http://dx.doi.org/10.1007/s10350-005-0052-6
  • Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS. Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study. Cell Transplant 2013; 22:279-85; PMID:23006344; http://dx.doi.org/10.3727/096368912X656045
  • de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A. Expanded allogenic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis 2013; 28:313-23; PMID:23053677; http://dx.doi.org/10.1007/s00384-012-1581-9
  • Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, Kim do S, Jung SH, Kim M, Yoo HW, Kim I, et al. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula. Stem Cells 2013; 31:2575-81; PMID:23404825; http://dx.doi.org/10.1002/stem.1357
  • Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009; 52:79-86; PMID:19273960; http://dx.doi.org/10.1007/DCR.0b013e3181973487
  • Herreros M, Guadalajara H, De-La-Quintana P, Pascual I, Trebol J, Georgiev-Hristov T, Gonzalez-Gomez C, Garcia-Arranz M, Del-Valle E, Zorrilla J, et al. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long term evaluation. Dis Colon Rectum 2012; 55:762-72; PMID:22706128; http://dx.doi.org/10.1097/DCR.0b013e318255364a
  • Csontos AA, Molnar A, Piri Z, Katona B, Dako S, Palfi E, Miheller P. The effect of anti TNFa induction therapy on the nutritional status and dietary intake in inflammatory bowel disease. J Gastrointestin Liver Dis 2016; 25:49-56; PMID:27014753; http://dx.doi.org/10.15403/jgld.2014.1121.251.tnf
  • Wang WZ, Fang XH, Williams SJ, Stephenson LL, Baynosa RC, Wong N, Khiabani KT, Zamboni WA. Analysis for apoptosis and necrosis on adipocytes, stromal vascular fraction, and adipose adipose-derived stem cells in human lipoaspirates after liposuction. Plast Reconstr Surg 2013; 131:77e-85e; PMID:23271558; http://dx.doi.org/10.1097/PRS.0b013e3182729ff7
  • Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L. Isolation and characterization of human mesenchymal stromal cell subpopulations: comparison of bone marrow and adipose tissue. Stem Cells Dev 2015; 24:2142-57; PMID:26086188; http://dx.doi.org/10.1089/scd.2015.0172
  • Hicok KC, Hedrick MH. Automated isolation and processing of adipose-derived stem and regenerative cells. Methods Mol Biol 2011; 702:87-105; PMID:21082397; http://dx.doi.org/10.1007/978-1-61737-960-4_8
  • Güven S, Karagianni M, Schwalbe M, Schreiner S, Farhadi J, Bula S, Bieback K, Martin I, Scherberich A. Validation of an automated procedure to isolate human adipose tissue-drived cells using the Sepax technology. Tissue Eng Part C Methods 2012; 18:572-82; PMID:22372873; 10.1089/ten.TEC.2011.0617
  • Nicoletti GF, De Francesco F, D'Andrea F, Ferraro GA. Methods and procedures in adipose stem cells: state of the art and perspective for translation medicine. J Cell Physiol 2015; 230:489-95; PMID:25294367; http://dx.doi.org/10.1002/jcp.24837
  • Trovato L, Monti M, Del Fante C, Cervio M, Lampinen M, Ambrosio L, Redi CA, Perotti C, Kankuri E, Ambrosio G, et al. A New medical device rigeneracons allows to obtain viable micro-grafts from mechanical disaggregation of human tissues. J Cell Physiol 2015; 230:2299-303; PMID:25728337; http://dx.doi.org/10.1002/jcp.24973
  • Purpura V, Bondioli E, Graziano A, Trovato L, Melandri D, Ghetti M, Marchesini A, Cusella De Angelis MG, Benedetti L, Ceccarelli G, et al. Tissue Characterization after a new disaggregation method for skin micro-grafts generation. J Vis Exp 2016; PMID:26967938; http://dx.doi.org/10.3791/53579
  • Carelli S, Messaggio F, Canazza A, Hebda DM, Caremoli F, Latorre E, Grimoldi MG, Colli M, Bulfamante G, Tremolada C, et al. Characteristics and properties of mesenchymal stem cells derived from microfragmented adipose tissue. Cell Transplant 2015; 24:1233-52; PMID:24806078; http://dx.doi.org/10.3727/096368914X681603

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.